Welcome to Cohesion Biosciences
Home> Products > Primary Antibody
CPA3279
  • Western blot analysis of Nibrin (Phospho-S343) expression in Jurkat (A), LO2 UV-treated (B), Raw264.7 UV-treated (C), PC12 (D) whole cell lysates. (Predicted band size: 84 kD; Observed band size: 95 kD)
Product Name:Anti-Nibrin (Phospho-S343) Antibody
Cat No:CPA3279
Source:Rabbit
Reactivity:H, M, R
Applications:WB
*Application Key:
H - Human, M - Mouse, R - Rat, B - Bovine, C - Chicken, D - Dog, G - Goat, Mk - Monkey, P - Pig, Rb - Rabbit, S - Sheep, Z - Zebrafish
*Species Reactivity Key:
E- ELISA, WB - Western blot, IH - Immunohistochemistry, IF - Immunofluorescence, FC - Flow cytometry, IC - Immunocytochemistry, IP - Immunoprecipitation, ChIP - Chromatin Immunoprecipitation, EMSA - Electrophoretic Mobility Shift Assay, BL - Blocking, SE - Sandwich ELISA, CBE - Cell-based ELISA, RNAi - RNA interference
Size
Price(USD)
200 μl
420
100 μl
260
30 μl
130
50 μl
170
Add to cart Ship in 3 days My orders
Description:Rabbit polyclonal antibody to Nibrin (Phospho-S343)
Immunogen:KLH-conjugated synthetic phosphopeptide corresponding to residues surrounding S343 of human Nibrin protein. The exact sequence is proprietary.
Purification:The antibody was purified by immunogen affinity chromatography.
Clonality:Polyclonal
Form:Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.
Dilution:WB (1/500 - 1/1000)
Gene Symbol:NBN
Alternative Names:NBS; NBS1; P95; Nibrin; Cell cycle regulatory protein p95; Nijmegen breakage syndrome protein 1
Entrez Gene (Human): 4683;
Entrez Gene (Mouse): 27354;
Entrez Gene (Rat): 85482;
SwissProt (Human): O60934;
SwissProt (Mouse): Q9R207;
SwissProt (Rat): Q9JIL9;
Storage/Stability:Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
  • Western blot analysis of Nibrin (Phospho-S343) expression in Jurkat (A), LO2 UV-treated (B), Raw264.7 UV-treated (C), PC12 (D) whole cell lysates. (Predicted band size: 84 kD; Observed band size: 95 kD)
The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo
Journal Blood
IF 20.3
Application WB
Reactivity Human
PMID 20739657
Requirement for NBS1 in the S phase checkpoint response to DNA methylation combined with PARP inhibition
Journal DNA Repair
IF 3.8
Application WB
Reactivity Human
PMID 21130714
Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours
Journal Br J Cancer
IF 8.8
Application WB
Reactivity Human
PMID 21792198
Direct Activation of ATM by Resveratrol under Oxidizing Conditions
Journal PLoS One
IF 3.7
Application WB
Reactivity Human
PMID 24933654
COHESION BIOSCIENCES LIMITED
Copyright © 2022 Cohesion Biosciences. All Rights Reserved